{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:49:26Z","timestamp":1791262166518,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03648-5","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T11:01:56Z","timestamp":1703329316000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-na\u00efve transgender people assigned female at birth"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-944X","authenticated-orcid":false,"given":"Seda Hanife","family":"O\u011fuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8987-3747","authenticated-orcid":false,"given":"Beyza Seda","family":"Boyraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-6387","authenticated-orcid":false,"given":"Banu","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"B\u00fclent Okan","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"issue":"12","key":"3648_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"G. Bozdag, S. Mumusoglu, D. Zengin et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12), 2841\u20132855 (2016). https:\/\/doi.org\/10.1093\/humrep\/dew218.","journal-title":"Hum Reprod"},{"issue":"1","key":"3648_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF01542305","volume":"15","author":"W Futterweit","year":"1986","unstructured":"W. Futterweit, R.A. Weiss, R.M. Fagerstrom, Endocrine evaluation of forty female-to-male transsexuals: increased frequency of polycystic ovarian disease in female transsexualism. Arch Sex Behav 15(1), 69\u201378 (1986). https:\/\/doi.org\/10.1007\/BF01542305.","journal-title":"Arch Sex Behav"},{"issue":"3","key":"3648_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2265.1993.tb01013.x","volume":"38","author":"AH Balen","year":"1993","unstructured":"A.H. Balen, M.E. Schachter, D. Montgomery et al. Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol (Oxf) 38(3), 325\u2013329 (1993). https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb01013.x. PubMed PMID: 8458105.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"3648_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0306-4530(97)00033-4","volume":"22","author":"HA Bosinski","year":"1997","unstructured":"H.A. Bosinski, M. Peter, G. Bonatz et al. A higher rate of hyperandrogenic disorders in female-to-male transsexuals. Psychoneuroendocrinology 22(5), 361\u2013380 (1997). https:\/\/doi.org\/10.1016\/s0306-4530(97)00033-4. PubMed PMID: 9279941.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"3648_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/humrep\/del474","volume":"22","author":"T Baba","year":"2007","unstructured":"T. Baba, T. Endo, H. Honnma et al. Association between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod 22(4), 1011\u20131016 (2007). https:\/\/doi.org\/10.1093\/humrep\/del474. Epub 20061213PubMed PMID: 17166864.","journal-title":"Hum Reprod"},{"issue":"4","key":"3648_CR6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1210\/jc.2007-2808","volume":"93","author":"A Mueller","year":"2008","unstructured":"A. Mueller, L.J. Gooren, S. Naton-Schotz et al. Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. J Clin Endocrinol Metab 93(4), 1408\u20131411 (2008). https:\/\/doi.org\/10.1210\/jc.2007-2808. Epub 20080122PubMed PMID: 18211977.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3648_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1743-6109.2008.00799.x","volume":"6","author":"S Vujovic","year":"2009","unstructured":"S. Vujovic, S. Popovic, G. Sbutega-Milosevic et al. Transsexualism in Serbia: a twenty-year follow-up study. J Sex Med 6(4), 1018\u20131023 (2009). https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00799.x. Epub 20080304PubMed PMID: 18331254.","journal-title":"J Sex Med"},{"issue":"7","key":"3648_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.endonu.2014.01.010","volume":"61","author":"A Becerra-Fernandez","year":"2014","unstructured":"A. Becerra-Fernandez, G. Perez-Lopez, M.M. Roman et al. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals. Endocrinol Nutr 61(7), 351\u2013358 (2014). https:\/\/doi.org\/10.1016\/j.endonu.2014.01.010. Epub 20140326PubMed PMID: 24680383.","journal-title":"Endocrinol Nutr"},{"issue":"6","key":"3648_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1089\/trgh.2021.0061","volume":"7","author":"E Gezer","year":"2022","unstructured":"E. Gezer, B. Piro, Z. Canturk et al. The comparison of gender dysphoria, body image satisfaction and quality of life between treatment-naive transgender males with and without polycystic ovary syndrome. Transgend Health 7(6), 514\u2013520 (2022). https:\/\/doi.org\/10.1089\/trgh.2021.0061. Epub 20221129PubMed PMID: 36644121; PubMed Central PMCID: PMCPMC9829140.","journal-title":"Transgend Health"},{"issue":"11","key":"3648_CR10","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"W.C. Hembree, P.T. Cohen-Kettenis, L. Gooren et al. Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(11), 3869\u20133903 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01658. PubMed PMID: 28945902.","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"3648_CR11","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1001\/jama.2023.8121","volume":"329","author":"T Poteat","year":"2023","unstructured":"T. Poteat, A.M. Davis, A. Gonzalez, Standards of care for transgender and gender diverse people. JAMA 329(21), 1872\u20131874 (2023). https:\/\/doi.org\/10.1001\/jama.2023.8121. PubMed PMID: 37200007.","journal-title":"JAMA"},{"issue":"1","key":"3648_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"B.O. Yildiz, S. Bolour, K. Woods et al. Visually scoring hirsutism. Hum Reprod Update 16(1), 51\u201364 (2010). https:\/\/doi.org\/10.1093\/humupd\/dmp024. PubMed PMID: 19567450; PubMed Central PMCID: PMCPMC2792145.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"3648_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","volume":"41","author":"SH Oguz","year":"2020","unstructured":"S.H. Oguz, I. Idilman, N. Helvaci et al. Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome. Reprod Biomed Online 41(2), 329\u2013334 (2020). https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.024. Epub 20200515PubMed PMID: 32576491.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"3648_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","volume":"39","author":"G Bozdag","year":"2019","unstructured":"G. Bozdag, S. Mumusoglu, Z.Y. Coskun et al. Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population. Reprod Biomed Online 39(3), 522\u2013529 (2019). https:\/\/doi.org\/10.1016\/j.rbmo.2019.04.002. Epub 20190410PubMed PMID: 31182353.","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"3648_CR15","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1093\/humrep\/dez185","volume":"34","author":"R Azziz","year":"2019","unstructured":"R. Azziz, K. Kintziger, R. Li et al. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource. Hum Reprod 34(11), 2254\u20132265 (2019). https:\/\/doi.org\/10.1093\/humrep\/dez185. PubMed PMID: 31751476.","journal-title":"Hum Reprod"},{"issue":"1","key":"3648_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva, L. Suturina, W. Walker et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1), 6\u201315 (2016). https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003. Epub 20160524PubMed PMID: 27233760.","journal-title":"Fertil Steril"},{"issue":"3","key":"3648_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12020-023-03421-8","volume":"81","author":"F Pallotti","year":"2023","unstructured":"F. Pallotti, G. Senofonte, A.C. Conflitti et al. Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen beta receptor polymorphisms with clinical outcomes. Endocrine 81(3), 621\u2013630 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03421-8. Epub 20230616PubMed PMID: 37326767.","journal-title":"Endocrine"},{"issue":"11","key":"3648_CR18","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1515\/jpem-2022-0249","volume":"35","author":"CL Schweisberger","year":"2022","unstructured":"C.L. Schweisberger, L. Hornberger, R. Barral et al. Gender diversity in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 35(11), 1422\u20131428 (2022). https:\/\/doi.org\/10.1515\/jpem-2022-0249. Epub 20221005PubMed PMID: 36198004; PubMed Central PMCID: PMCPMC10274191.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"3648_CR19","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1210\/clinem\/dgad388","volume":"108","author":"DS Lopez","year":"2023","unstructured":"D.S. Lopez, J.S. Mulla, D. El Haddad et al. Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people. J Clin Endocrinol Metab 108(12), e1515\u2013e1523 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad388. PubMed PMID: 37392459; PubMed Central PMCID: PMCPMC10655536.","journal-title":"J Clin Endocrinol Metab"},{"key":"3648_CR20","doi-asserted-by":"publisher","first-page":"117282","DOI":"10.1016\/j.atherosclerosis.2023.117282","volume":"384","author":"CN Murphy","year":"2023","unstructured":"C.N. Murphy, C. Delles, E. Davies et al. Cardiovascular disease in transgender individuals. Atherosclerosis 384, 117282 (2023). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117282. Epub 20230909PubMed PMID: 37821271.","journal-title":"Atherosclerosis"},{"issue":"11","key":"3648_CR21","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"S. Maraka, N. Singh Ospina, R. Rodriguez-Gutierrez et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102(11), 3914\u20133923 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01643. PubMed PMID: 28945852.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3648_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","volume":"9","author":"CJ de Blok","year":"2021","unstructured":"C.J. de Blok, C.M. Wiepjes, D.M. van Velzen et al. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria. Lancet Diabetes Endocrinol 9(10), 663\u2013670 (2021). https:\/\/doi.org\/10.1016\/S2213-8587(21)00185-6. Epub 20210902PubMed PMID: 34481559.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"3648_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1530\/EJE-22-0306","volume":"187","author":"D Glintborg","year":"2022","unstructured":"D. Glintborg, K.H. Rubin, T.G. Petersen et al. Cardiovascular risk in Danish transgender persons: a matched historical cohort study. Eur J Endocrinol 187(3), 463\u2013477 (2022). https:\/\/doi.org\/10.1530\/EJE-22-0306. Epub 20220805PubMed PMID: 35900321.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3648_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.eprac.2022.12.017","volume":"29","author":"RMC Moreira Allgayer","year":"2023","unstructured":"R.M.C. Moreira Allgayer, G.D.S. Borba, R.S. Moraes et al. The effect of gender-affirming hormone therapy on the risk of subclinical atherosclerosis in the transgender population: a systematic review. Endocr Pract 29(6), 498\u2013507 (2023). https:\/\/doi.org\/10.1016\/j.eprac.2022.12.017. Epub 20230102PubMed PMID: 36603652.","journal-title":"Endocr Pract"},{"issue":"4","key":"3648_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"D. Getahun, R. Nash, W.D. Flanders et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 169(4), 205\u2013213 (2018). https:\/\/doi.org\/10.7326\/M17-2785. Epub 20180710PubMed PMID: 29987313; PubMed Central PMCID: PMCPMC6636681.","journal-title":"Ann Intern Med"},{"issue":"11","key":"3648_CR26","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","volume":"139","author":"NM Nota","year":"2019","unstructured":"N.M. Nota, C.M. Wiepjes, C.J.M. de Blok et al. Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy. Circulation 139(11), 1461\u20131462 (2019). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038584. PubMed PMID: 30776252.","journal-title":"Circulation"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03648-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:08:14Z","timestamp":1712110094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03648-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3648"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03648-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,23]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Hacettepe University, Ankara, Turkey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}